- The shares of Applied DNA Sciences ( NASDAQ: APDN ) added 51% in the morning hours Monday after the life sciences company announced that it received its largest single purchase order for LinearDNA, an alternative to the current manufacturing standard for DNA.
- The long-term supply agreement valued above mid-six figures involves the bulk manufacture of LinearDNA.
- APDN said that the transaction is a repeat order under which the company will deliver LinearDNA to a global manufacturer of in vitro diagnostics starting from the current quarter. The full order is expected to complete over the next three quarters.
For further details see:
Applied DNA climbs 51% after winning large purchase order